🔗 Share this article

This year's prestigious award in medical science was awarded for transformative findings that clarify how the immune system attacks harmful pathogens while sparing the healthy tissues.

A trio of esteemed scientists—from Japan Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this honor.

The work identified unique "sentinels" within the defense system that eliminate malfunctioning immune cells capable of attacking the body.

These findings are now paving the way for innovative therapies for immune disorders and cancer.

The winners will divide a monetary award valued at 11 million Swedish kronor.

Crucial Findings

"Their work has been essential for comprehending how the body's defenses operates and why we don't all suffer from serious self-attack conditions," stated the head of the Nobel Committee.

The team's research address a core mystery: In what way does the defense system protect us from countless infections while leaving our own tissues intact?

Our body's protection system employs white blood cells that scan for indicators of infection, including pathogens and germs it has not met before.

These defenders employ detectors—known as recognition units—that are produced randomly in a vast number of variations.

That provides the immune system the capacity to combat a wide array of invaders, but the randomness of the mechanism inevitably produces white blood cells that may target the body.

Protectors of the Body

Researchers earlier understood that a portion of these problematic defense cells were eliminated in the thymus—where white blood cells develop.

This year's award recognizes the discovery of regulatory T-cells—described as the body's "security guards"—which patrol the system to disarm any immune cells that attack the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel added, "These findings have laid the foundation for a novel area of research and accelerated the development of innovative treatments, for instance for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells prevent the system from attacking the growth, so studies are focused on lowering their quantity.

For autoimmune diseases, experiments are testing boosting T-reg cells so the organism is no longer being harmed. A comparable method could also be useful in reducing the chances of organ transplant failure.

Pioneering Studies

Professor Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher showed that injecting immune cells from other mice could prevent the disease—suggesting there was a mechanism for blocking defenders from attacking the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in mice and humans that led to the identification of a genetic factor vital for the way T-regs operate.

"Their groundbreaking work has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally attacking the body's own tissues," commented a prominent biological science specialist.

"This work is a striking illustration of how basic biological study can have far-reaching consequences for public health."